Skip to main content
. 2017 Sep 18;47(6):918–928. doi: 10.4070/kcj.2016.0443

Table 1. Patient characteristics.

Variables No LVH + low TACS (n=171) LVH + low TACS (n=73) No LVH + high TACS (n=168) LVH + high TACS (n=75) p value*
Age (years) 69±3 69±3 71±4 70±4 <0.001
Male 80 (46.5) 13 (17.8) 96 (57.1) 18 (24.3) <0.001
Hypertension 86 (50.0) 44 (60.2) 101 (60.1) 48 (64.8) 0.107
Diabetes mellitus 23 (13.3) 12 (16.4) 42 (25.0) 13 (17.6) 0.050
Dyslipidemia 85 (49.4) 29 (39.7) 88 (52.3) 36 (48.6) 0.331
BMI (kg/m2) 24.3±2.7 24.8±2.8 24.6±2.7 25.4±3.5 0.038
Laboratory test (g/dL)
Creatinine 0.94±0.24 0.87±0.15 0.99±0.20 0.91±0.24 <0.001
LDL-cholesterol 112.2±32.2 113.7±32.2 112.7±37.1 124.2±50.0 0.686
HDL-cholesterol 51.0±13.5 52.2±12.1 50.0±11.7 50.1±11.7 0.199
CT variables (mm3)
TACS 120 (37–261) 149 (47–261) 1,226 (790–2,291) 1,284 (747–2,336) <0.001
CACS 0 (0–27) 0 (0–20) 28 (0–161) 13 (0–95) 0.001
Echocardiography
LVEDD (mm) 46.5±3.7 49.6±3.7 46.3±4.1 49.5±4.3 <0.001
LVESD (mm) 30.2±3.7 32.3±3.7 30.2±3.5 32.2±4.2 <0.001
LVEF (%) 67.3±7.2 67.3±6.3 66.9±5.9 67.1±6.8 0.960
LVMI (g/m2) 80.7±14.5 111.4±13.6 83.3±13.0 117.6±16.0 <0.001
E/e' 11.0±3.3 11.3±2.9 11.5±4.0 13.1±3.8 0.001

Values are presented as mean±standard deviation, median (range), or number of patients (%).

ANOVA = analysis of variance; BMI = body mass index; CACS = coronary artery calcium score; CT = computed tomography; E/e' = the ratio of early diastolic mitral inflow to mitral annular velocity; HDL = high density lipoprotein; LDL = low density lipoprotein; LVEDD = left ventricular end-diastolic dimension; LVEF = left ventricular ejection fraction; LVESD = left ventricular end-systolic dimension; LVH = left ventricular hypertrophy; LVMI = left ventricular mass index; TACS = thoracic aorta calcium score.

*p values were calculated by ANOVA for continuous variables and by χ2 test for categorical variables.